Circulating MicroRNA Profiles Differ between Qi-Stagnation and Qi-Deficiency in Coronary Heart Disease Patients with Blood Stasis Syndrome

Table 3

(a) Upregulated pathways in patients with QDB syndrome. (b) Downregulated pathways in patients with QDB syndrome.

(a)

Path_ID	Path_name	Count	%	value	FDR
hsa04144	Endocytosis	41	0.245627
hsa04360	Axon guidance	28	0.167745		0.00157
hsa05212	Pancreatic cancer	15	0.089863	0.003962	0.126948
hsa04010	MAPK signaling pathway	36	0.215672	0.01223	0.259629
hsa05220	Chronic myeloid leukemia	14	0.083873	0.014293	0.239301
hsa04070	Phosphatidylinositol signaling system	13	0.077882	0.029505	0.400777
hsa04810	Regulation of actin cytoskeleton	28	0.167745	0.041864	0.485632
hsa04012	ErbB signaling pathway	14	0.083873	0.043572	0.469973

(b)

Path_ID	Path_name	Count	%	value	FDR
hsa04012	ErbB signaling pathway	18	1.880878		0.001671
hsa05214	Glioma	14	1.462905		0.00503
hsa04910	Insulin signaling pathway	21	2.194357		0.006429
hsa04510	Focal adhesion	27	2.821317		0.005062
hsa04730	Long-term depression	13	1.358412		0.016838
hsa05220	Chronic myeloid leukemia	13	1.358412	0.001496	0.030734
hsa04720	Long-term potentiation	12	1.253918	0.002133	0.038212
hsa04722	Neurotrophin signaling pathway	17	1.776385	0.002769	0.039679
hsa04150	mTOR signaling pathway	10	1.044932	0.003329	0.043298
hsa05212	Pancreatic cancer	12	1.253918	0.003394	0.04052